MapLight Therapeutics, Inc. (MPLT) SEC filings
MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.57−0.33 (-4.78%)
Close on Nov 17, 2026Market cap $304.70MP/E –Yield –
SEC filings
19 of MapLight Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 16, 2026 | Nov 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 16, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 16, 2026 | Nov 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2026 | Apr 29, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 23, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Dec 4, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 26, 2025 | Oct 29, 2025 | SEC EDGAR |
See a number that looks wrong?